Vanguard Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$818M Sell
4,993,945
-50,246
-1% -$7.87M 0.01% 801
2025
Q3
$674M Sell
5,044,191
-32,981
-0.6% -$4.01M 0.01% 891
2025
Q2
$631M Sell
5,077,172
-2,722
-0.1% -$346K 0.01% 902
2025
Q1
$646M Sell
5,079,894
-21,196
-0.4% -$3.26M 0.01% 846
2024
Q4
$734M Buy
5,101,090
+56,723
+1% +$8.13M 0.01% 828
2024
Q3
$751M Sell
5,044,367
-22,002
-0.4% -$3.15M 0.01% 803
2024
Q2
$639M Sell
5,066,369
-33,644
-0.7% -$5.27M 0.01% 842
2024
Q1
$938M Buy
5,100,013
+21,719
+0.4% +$4.14M 0.02% 675
2023
Q4
$913M Buy
5,078,294
+33,404
+0.7% +$5.2M 0.02% 659
2023
Q3
$802M Sell
5,044,890
-11,508
-0.2% -$1.88M 0.02% 670
2023
Q2
$715M Sell
5,056,398
-25,521
-0.5% -$4.09M 0.02% 728
2023
Q1
$856M Sell
5,081,919
-123,236
-2% -$22M 0.02% 645
2022
Q4
$881M Buy
5,205,155
+76,271
+1% +$13.8M 0.02% 625
2022
Q3
$960M Buy
5,128,884
+24,998
+0.5% +$5.27M 0.03% 574
2022
Q2
$829M Buy
5,103,886
+212,282
+4% +$33.6M 0.02% 623
2022
Q1
$920M Sell
4,891,604
-21,165
-0.4% -$4.02M 0.02% 657
2021
Q4
$1.3B Buy
4,912,769
+41,509
+0.9% +$11.2M 0.03% 567
2021
Q3
$1.41B Sell
4,871,260
-22,771
-0.5% -$5.84M 0.04% 523
2021
Q2
$977M Buy
4,894,031
+32,003
+0.7% +$6.21M 0.02% 667
2021
Q1
$945M Buy
4,862,028
+451,286
+10% +$92.5M 0.03% 646
2020
Q4
$845M Buy
4,410,742
+159,212
+4% +$29M 0.02% 639
2020
Q3
$627M Sell
4,251,530
-134,222
-3% -$19.2M 0.02% 687
2020
Q2
$542M Sell
4,385,752
-164,533
-4% -$19.4M 0.02% 724
2020
Q1
$439M Buy
4,550,285
+81,138
+2% +$7.83M 0.02% 713
2019
Q4
$413M Buy
4,469,147
+95,496
+2% +$8.02M 0.01% 927
2019
Q3
$335M Sell
4,373,651
-46,834
-1% -$4.1M 0.01% 1009
2019
Q2
$380M Buy
4,420,485
+305,195
+7% +$20.8M 0.01% 947
2019
Q1
$243M Buy
4,115,290
+84,619
+2% +$4.87M 0.01% 1223
2018
Q4
$213M Buy
4,030,671
+107,536
+3% +$6.31M 0.01% 1214
2018
Q3
$218M Buy
3,923,135
+868,093
+28% +$44.7M 0.01% 1326
2018
Q2
$144M Buy
3,055,042
+96,343
+3% +$3.97M 0.01% 1569
2018
Q1
$107M Buy
2,958,699
+131,704
+5% +$4.63M ﹤0.01% 1681
2017
Q4
$103M Sell
2,826,995
-8,087
-0.3% -$293K ﹤0.01% 1704
2017
Q3
$109M Buy
2,835,082
+850,689
+43% +$35.7M 0.01% 1653
2017
Q2
$82.2M Buy
1,984,393
+175,191
+10% +$6.66M ﹤0.01% 1776
2017
Q1
$63.7M Buy
1,809,202
+118,585
+7% +$3.76M ﹤0.01% 1881
2016
Q4
$52.1M Buy
1,690,617
+52,848
+3% +$1.63M ﹤0.01% 1955
2016
Q3
$49.4M Buy
1,637,769
+72,061
+5% +$2.17M ﹤0.01% 1934
2016
Q2
$42.8M Buy
1,565,708
+102,030
+7% +$2.61M ﹤0.01% 1969
2016
Q1
$39.3M Buy
1,463,678
+62,901
+4% +$1.54M ﹤0.01% 1980
2015
Q4
$39.6M Buy
1,400,777
+55,896
+4% +$1.61M ﹤0.01% 1995
2015
Q3
$37.5M Buy
1,344,881
+78,378
+6% +$2.83M ﹤0.01% 2007
2015
Q2
$52.3M Buy
1,266,503
+19,420
+2% +$711K ﹤0.01% 1920
2015
Q1
$37.9M Buy
1,247,083
+60,097
+5% +$1.56M ﹤0.01% 2039
2014
Q4
$23.5M Buy
1,186,986
+39,880
+3% +$892K ﹤0.01% 2176
2014
Q3
$22.8M Buy
1,147,106
+33,501
+3% +$705K ﹤0.01% 2149
2014
Q2
$25.4M Buy
1,113,605
+220,552
+25% +$3.93M ﹤0.01% 2126
2014
Q1
$11.5M Buy
893,053
+49,185
+6% +$705K ﹤0.01% 2418
2013
Q4
$11.5M Buy
843,868
+42,792
+5% +$511K ﹤0.01% 2399
2013
Q3
$8.88M Buy
801,076
+1,242
+0.2% +$12.4K ﹤0.01% 2451
2013
Q2
$6.59M Buy
+799,834
New +$6.72M ﹤0.01% 2519

Other funds holding RGEN

Vanguard Group's RGEN Position: Q4 2025 in Review

Vanguard Group reduced its Repligen (RGEN) stake by 1% in Q4 2025, selling an estimated $7.87M and leaving 4,993,945 shares worth $818M. The position accounts for 0.01% of the portfolio, ranked #801.

Vanguard Group first reported a position in RGEN in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.41B in Q3 2021. 473 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Vanguard Group held 4,993,945 shares of Repligen worth $818M as of Q4 2025.
  • Vanguard Group sold 50,246 Repligen shares in Q4 2025, an estimated $7.87M.
  • Repligen made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #801 holding.
  • Vanguard Group first reported a position in Repligen in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Repligen position peaked at $1.41B in Q3 2021.
  • 473 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.